XML 124 R105.htm IDEA: XBRL DOCUMENT v3.6.0.2
Guarantor and Non-Guarantor Supplemental Financial Information - Schedule of Cash Flow Statement Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating activities:      
Net cash provided by operating activities $ 1,564,334,000 $ 1,368,045,000 $ 1,366,959,000
Investing activities:      
Capital expenditures, including internal-use software and website development (749,348,000) (787,041,000) (328,387,000)
Purchases of investments (45,352,000) (521,329,000) (1,194,210,000)
Sales and maturities of investments 60,935,000 410,923,000 1,162,557,000
Acquisitions, net of cash acquired (777,000) (2,063,649,000) (560,668,000)
Transfers (to) from related parties 0 0  
Proceeds from sale of business, net of cash divested and disposal costs 67,088,000 523,882,000 0
Other, net (50,867,000) 65,954,000 (3,549,000)
Net cash used in investing activities (718,321,000) (2,371,260,000) (924,257,000)
Financing activities:      
Proceeds from issuance of long-term debt, net of issuance costs (2,093,000) 1,441,860,000 492,894,000
Payment of HomeAway Convertible Notes (401,424,000) 0 0
Purchases of treasury stock (455,746,000) (60,546,000) (537,861,000)
Proceeds from issuance of treasury stock 0 22,575,000 20,404,000
Payment of dividends to stockholders (150,159,000) (108,527,000) (84,697,000)
Proceeds from exercise of equity awards and employee stock purchase plan 141,043,000 97,716,000 108,121,000
Withholding taxes for stock option exercises (1,282,000) (85,033,000) 0
Sales (purchases) of interest in controlled subsidiaries, net 208,016,000 (8,518,000) (3,272,000)
Transfers (to) from related parties 0 0 0
Other, net (28,974,000) 104,672,000 52,560,000
Net cash provided by (used in) financing activities (690,619,000) 1,404,199,000 48,149,000
Effect of exchange rate changes on cash and cash equivalents (34,882,000) (127,385,000) (109,184,000)
Net increase in cash and cash equivalents 120,512,000 273,599,000 381,667,000
Cash and cash equivalents at beginning of year 1,676,299,000 1,402,700,000 1,021,033,000
Cash and cash equivalents at end of year 1,796,811,000 1,676,299,000 1,402,700,000
Reportable Legal Entities | Parent      
Operating activities:      
Net cash provided by operating activities 0 0 0
Investing activities:      
Capital expenditures, including internal-use software and website development 0 0 0
Purchases of investments 0 0 0
Sales and maturities of investments 0 0 0
Acquisitions, net of cash acquired 0 (126,779,000) 0
Transfers (to) from related parties 0 126,779,000  
Proceeds from sale of business, net of cash divested and disposal costs 0 0  
Other, net 0 0 0
Net cash used in investing activities 0 0 0
Financing activities:      
Proceeds from issuance of long-term debt, net of issuance costs (2,093,000) 1,441,860,000 492,894,000
Payment of HomeAway Convertible Notes 0    
Purchases of treasury stock (455,746,000) (60,546,000) (537,861,000)
Proceeds from issuance of treasury stock   22,575,000 20,404,000
Payment of dividends to stockholders (150,159,000) (108,527,000) (84,697,000)
Proceeds from exercise of equity awards and employee stock purchase plan 141,043,000 96,526,000 104,598,000
Withholding taxes for stock option exercises (1,282,000) (85,033,000)  
Sales (purchases) of interest in controlled subsidiaries, net 0 0 0
Transfers (to) from related parties 468,511,000 (1,396,210,000) (53,494,000)
Other, net (274,000) 89,355,000 58,156,000
Net cash provided by (used in) financing activities 0 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net increase in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of year 0 0 0
Cash and cash equivalents at end of year 0 0 0
Reportable Legal Entities | Guarantor Subsidiaries      
Operating activities:      
Net cash provided by operating activities 940,191,000 624,327,000 1,027,571,000
Investing activities:      
Capital expenditures, including internal-use software and website development (635,534,000) (709,679,000) (281,696,000)
Purchases of investments 0 (473,538,000) (913,205,000)
Sales and maturities of investments 37,830,000 327,191,000 861,744,000
Acquisitions, net of cash acquired 0 (1,873,079,000) 0
Transfers (to) from related parties (172,731,000) (303,846,000)  
Proceeds from sale of business, net of cash divested and disposal costs 0 0  
Other, net (50,029,000) 54,226,000 (2,805,000)
Net cash used in investing activities (820,464,000) (2,978,725,000) (335,962,000)
Financing activities:      
Proceeds from issuance of long-term debt, net of issuance costs 0 0 0
Payment of HomeAway Convertible Notes (401,424,000)    
Purchases of treasury stock 0 0 0
Proceeds from issuance of treasury stock   0 0
Payment of dividends to stockholders 0 0 0
Proceeds from exercise of equity awards and employee stock purchase plan 0 0 0
Withholding taxes for stock option exercises 0 0  
Sales (purchases) of interest in controlled subsidiaries, net 0 0 0
Transfers (to) from related parties (118,179,000) 2,350,385,000 (287,394,000)
Other, net (1,484,000) (11,998,000) (2,124,000)
Net cash provided by (used in) financing activities (521,087,000) 2,338,387,000 (289,518,000)
Effect of exchange rate changes on cash and cash equivalents (14,865,000) (86,269,000) (64,798,000)
Net increase in cash and cash equivalents (416,225,000) (102,280,000) 337,293,000
Cash and cash equivalents at beginning of year 841,696,000 943,976,000 606,683,000
Cash and cash equivalents at end of year 425,471,000 841,696,000 943,976,000
Reportable Legal Entities | Non-Guarantor Subsidiaries      
Operating activities:      
Net cash provided by operating activities 624,143,000 743,718,000 339,388,000
Investing activities:      
Capital expenditures, including internal-use software and website development (113,814,000) (77,362,000) (46,691,000)
Purchases of investments (45,352,000) (47,791,000) (281,005,000)
Sales and maturities of investments 23,105,000 83,732,000 300,813,000
Acquisitions, net of cash acquired (777,000) (63,791,000) (560,668,000)
Transfers (to) from related parties 172,731,000 177,067,000  
Proceeds from sale of business, net of cash divested and disposal costs 67,088,000 523,882,000  
Other, net (838,000) 11,728,000 (744,000)
Net cash used in investing activities 102,143,000 607,465,000 (588,295,000)
Financing activities:      
Proceeds from issuance of long-term debt, net of issuance costs 0 0 0
Payment of HomeAway Convertible Notes 0    
Purchases of treasury stock 0 0 0
Proceeds from issuance of treasury stock   0 0
Payment of dividends to stockholders 0 0 0
Proceeds from exercise of equity awards and employee stock purchase plan 0 1,190,000 3,523,000
Withholding taxes for stock option exercises 0 0  
Sales (purchases) of interest in controlled subsidiaries, net 208,016,000 (8,518,000) (3,272,000)
Transfers (to) from related parties (350,332,000) (954,175,000) 340,888,000
Other, net (27,216,000) 27,315,000 (3,472,000)
Net cash provided by (used in) financing activities (169,532,000) (934,188,000) 337,667,000
Effect of exchange rate changes on cash and cash equivalents (20,017,000) (41,116,000) (44,386,000)
Net increase in cash and cash equivalents 536,737,000 375,879,000 44,374,000
Cash and cash equivalents at beginning of year 834,603,000 458,724,000 414,350,000
Cash and cash equivalents at end of year $ 1,371,340,000 $ 834,603,000 $ 458,724,000